Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

Función

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Appetite regulation: Enhances satiety signaling, leading to reduced caloric intake.
• Control del peso: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

Origen y normalización

• Fuente: Synthetic peptide, produced via solid-phase peptide synthesis.
• Normalización: Purity ≥98% (HPLC), peptide content 70-90%.
• Formularios: Lyophilized powder, acetate salt.
• Aplicaciones: Research on obesity, type 2 diabetes, and metabolic disorders.

Documentación y suministros

• Cantidad mínima de pedido: 5g
• Capacidad mensual: 1 kg
• Plazo de entrega: 5-10 days after order
• Documentación: Certificado de análisis (COA), Ficha de datos de seguridad (MSDS), Ficha técnica del producto (TDS)
• Embalaje: Sealed vials or custom packaging

Solicitud de presupuesto

• Nuestra dirección: Calle Main, 280, Xi'an, Shaanxi, China
• LyvBio S.L. — Correo electrónico: info@lyvbio.com